Pharmaceutical

GSK obtains approval in Japan for shingles vaccine

The Japanese MHLW has granted approval for a renewed indication of GSK's shingles (herpes zoster) vaccine, Shingrix.

Jun 27, 2023 - 20:00
GSK obtains approval in Japan for shingles vaccine
The Japanese MHLW has granted approval for a renewed indication of GSK's shingles (herpes zoster) vaccine, Shingrix.
Read the original article

Tags:

Previous Article

Inflation reduction act boosts biologic drug venture financing over small molecules

Next Article

Tonix to acquire Upsher-Smith’s migraine products

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Janssen launches once-daily option for prostate cancer drug Erleada

Janssen launches once-daily option for prostate cancer ...

Apr 4, 2023

EMA and FDA green-light MoonLake to advance IL-17 inhibitor

EMA and FDA green-light MoonLake to advance IL-17 inhib...

Feb 28, 2024

STAT+: Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial

STAT+: Breast cancer drug from AstraZeneca, Daiichi hit...

Sep 22, 2023